Paredes J., Albergaria A., Oliveira J. T., Jeronimo C., Milanezi F., and Schmitt F. C.,  "P-Cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation",  Clinical Cancer Research, vol. 15;11, issue 16, pp. 5869-77, 2005.